{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:04:35Z","timestamp":1792087475046,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21147"],"award-info":[{"award-number":["21147"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["5x1000"],"award-info":[{"award-number":["5x1000"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012100","name":"Associazione Italiana Contro le Leucemie-Linfomi e Mieloma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012100","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.imbio.2020.152001","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T01:49:00Z","timestamp":1596937740000},"page":"152001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab"],"prefix":"10.1016","volume":"225","author":[{"given":"Alessandro","family":"Rambaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Caterina","family":"Mic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Frigeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Borleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Sonzogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gianatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Binda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fagiuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Lorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Demopulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2020.152001_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19\u2019","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2020.152001_bib0010","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/bmt.2017.194","article-title":"Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation","volume":"52","author":"Almici","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.imbio.2020.152001_bib0015","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis?","volume":"141","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.imbio.2020.152001_bib0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0002-9440(10)65026-2","article-title":"Complement activation after oxidative stress: role of the lectin complement pathway","volume":"156","author":"Collard","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.imbio.2020.152001_bib0025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.imbio.2020.152001_bib0030","series-title":"Compositions and Methods of Inhibiting MASP-2 for the Treatment of Various Thrombotic Diseases and Disorders","author":"Demopulos","year":"2020"},{"key":"10.1016\/j.imbio.2020.152001_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.imbio.2020.152001_bib0040","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.imbio.2020.152001_bib0045","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3389\/fimmu.2018.01851","article-title":"Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases","volume":"9","author":"Dobo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2020.152001_bib0050","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1056\/NEJMc2011599","article-title":"Adaptations and lessons in the province of Bergamo","volume":"382","author":"Fagiuoli","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2020.152001_bib0055","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00134-012-2682-1","article-title":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material","volume":"38","author":"Ferguson","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.imbio.2020.152001_bib0060","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation","author":"Gao","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.imbio.2020.152001_bib0065","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.imbio.2020.152001_bib0070","doi-asserted-by":"crossref","first-page":"e01753","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.imbio.2020.152001_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.micinf.2020.05.006","article-title":"Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency","volume":"22","author":"Green","year":"2020","journal-title":"Microbes Infect."},{"key":"10.1016\/j.imbio.2020.152001_bib0080","article-title":"IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study","author":"Gritti","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.imbio.2020.152001_bib0085","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2020.152001_bib0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2567.2009.03200.x","article-title":"Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot","volume":"129","author":"Gulla","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2020.152001_bib0095","article-title":"Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report","author":"Horby","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.imbio.2020.152001_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.imbio.2020.152001_bib0105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2020.152001_bib0110","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1371\/journal.pone.0000623","article-title":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2","volume":"2","author":"Krarup","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2020.152001_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associatedmicrovascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.imbio.2020.152001_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2020.152001_bib0125","series-title":"Included in Narsoplimab Biologics License Application to the U.S. Food and Drug Administration","author":"Omeros Corporation","year":"2013"},{"key":"10.1016\/j.imbio.2020.152001_bib0130","series-title":"Included in Narsoplimab Biologics License Application to the U.S. Food and Drug Administration","author":"Omeros Corporation","year":"2013"},{"key":"10.1016\/j.imbio.2020.152001_bib0135","series-title":"Clinical Study Report for Study OMS721-NHV-001 \"Phase 1 Sequential Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose Administration of OMS721 in Healthy Male Subjects\"","author":"Omeros Corporation","year":"2019"},{"key":"10.1016\/j.imbio.2020.152001_bib0140","series-title":"EHA","article-title":"Narsoplimab (OMS721) for the treatment of adult hematopoietic stem cell transplant-associated thrombotic microangiopathy","author":"Rambaldi","year":"2020"},{"key":"10.1016\/j.imbio.2020.152001_bib0145","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(20)30627-9","article-title":"COVID-19 and Italy: what next?","volume":"395","author":"Remuzzi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2020.152001_bib0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1078\/0171-2985-00146","article-title":"The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes","volume":"205","author":"Schwaeble","year":"2002","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2020.152001_bib0155","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1073\/pnas.1101748108","article-title":"Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia\/reperfusion injury","volume":"108","author":"Schwaeble","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2020.152001_bib0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2020.152001_bib0165","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2020.152001_bib0170","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2020.152001_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fmed.2020.00170","article-title":"Use of corticosteroids in coronavirus disease 2019 pneumonia: a systematic review of the literature","volume":"7","author":"Veronese","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.imbio.2020.152001_bib0180","first-page":"M20","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.imbio.2020.152001_bib0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.imbio.2020.152001_bib0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.imbio.2020.152001_bib0195","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1096\/fj.201601306R","article-title":"Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and\/or C2","volume":"31","author":"Yaseen","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.imbio.2020.152001_bib0200","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520304459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520304459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:47:58Z","timestamp":1759250878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298520304459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0171298520304459"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152001","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152001"}}